Dr. Jian’an Wang Named Inaugural Editor-in-Chief of JACC: Asia

China-based physician scientist brings esteemed career in cardiovascular disease to journal editorship

Contact: Dana Kauffman, dkauffman@acc.org, 202-375-6294

WASHINGTON (Dec 21, 2020) -

Jian’an Wang, MD, PhD, FACC, has been named the inaugural editor-of-chief of JACC: Asia, the American College of Cardiology’s newest addition to its prestigious journal portfolio. The Journal will publish original manuscripts and clinical practice guidelines specific to Asian populations and by Asian authors.

Wang is a physician scientist who serves as the chair of the Heart Center at the Second Affiliated Hospital at Zhejiang University School of Medicine in China. He is also a professor and associate dean at Zhejiang University School of Medicine.

A leading interventional cardiologist, Wang has spearheaded the efforts in establishing and developing one of the largest valvular heart disease programs in Asia. Wang has also developed several innovative devices for valvular interventions, in collaboration with engineers, cardiovascular colleagues and manufacturers, that have been approved by the China Food and Drug Administration. His research work focuses on improving the efficacy of stem cell implantation in infarcted myocardium through hypoxemic preconditioning, which has been validated on rodent model, non-human primate model and phase-1 clinical studies.

“It is a great honor and privilege to serve as the first editor-in-chief of JACC: Asia,” Wang said. “Our editorial team is excited to gather and publish the important scientific cardiovascular research coming from China, Japan and South Korea to help improve cardiovascular care and save lives. We look forward to working closely with cardiovascular research authors in the region and the JACC team to achieve these efforts.”

Announced in July, JACC: Asia will be the first region-specific cardiovascular journal with original peer-reviewed content. The publication will be an online-only Open Access journal covering topics ranging from cardiovascular health and prevention to late-stage interventions specifically within East Asian populations. The Journal will also feature clinical practice guideline recommendations focused on Chinese, Japanese and South Korean patients who have or are at risk of developing cardiovascular disease.

The first issue of JACC: Asia will publish in early 2021.

The American College of Cardiology envisions a world where innovation and knowledge optimize cardiovascular care and outcomes. As the professional home for the entire cardiovascular care team, the mission of the College and its 54,000 members is to transform cardiovascular care and to improve heart health. The ACC bestows credentials upon cardiovascular professionals who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. The College also provides professional medical education, disseminates cardiovascular research through its world-renowned JACC Journals, operates national registries to measure and improve care, and offers cardiovascular accreditation to hospitals and institutions. For more, visit acc.org.

The Journal of the American College of Cardiology ranks among the top cardiovascular journals in the world for its scientific impact. JACC, published by Elsevier, is the flagship for a family of journals—JACC: Cardiovascular Interventions, JACC: Cardiovascular Imaging, JACC: Heart Failure, JACC: Clinical Electrophysiology, JACC: Basic to Translational Science, JACC: Case Reports and JACC: CardioOncology—that prides themselves in publishing the top peer-reviewed research on all aspects of cardiovascular disease. Learn more at JACC.org.


< Back to Listings